Home-Use Medical Device Instructions: Review Use Errors Before Translation

Instructions help users perform important actions correctly. Review translation and use errors together to find gaps between the screen, package and instructions.

1. Define the user beyond the patient

The purchaser, operator and helper can be different people. Establish whether an older user operates the product alone, a caregiver sets it up, or training precedes use. Consider vision, dexterity and literacy where relevant without inventing unsupported assumptions about the intended population.

Align the environment with product specifications. Determine whether dim lighting, noise, limited space, storage temperature or family use matter. Before describing the product as suitable for home use, check whether its registered intended use and evidence cover that setting. Moving a professional product into the home requires more than a translation project.

2. Review errors along the use sequence

The following is a practical review aid. Select actual steps important to the product's safety and performance rather than adding functions the product does not have.

Connect each row to possible consequences and existing risk controls. Prioritize critical interpretation and hazardous actions; not all errors have equal significance.

3. Make warnings specific about action, condition and reason

Use caution does not tell the reader which action to change. Based on the manufacturer's supported conditions, distinguish when to stop, what to inspect and what to avoid. Give a short reason users can understand.

When an error leads to repeat measurement, use the verified procedure for that error. Applying the same instruction to every abnormal display, or inserting an unsupported diagnostic threshold, can create confusion. Check approved use and manufacturer evidence for clinically meaningful information rather than inventing treatment actions during editing.

4. Some risks cannot be closed by editing alone

If controls or connectors are confusing, consider design and interface improvements before adding warnings. A warning on a later page may appear after the user has already acted. Check whether information is available when needed and whether quick-start material conflicts with the full instructions.

Controls specified in the risk analysis must appear in final instructions and screens. If evaluation used an old English interface but sales use a new Korean one, support the conclusion that the interfaces prompt the intended actions equivalently. See the usability guide and risk management guide.

5. Translation review must include values and graphics

Check units, decimal marks, model codes, interface terms, illustration directions and error numbers separately. Correct prose does not help if a drawing shows another model or the app and manual use different button names. Review truncated Korean screen text and whether key marks remain distinguishable in small illustrations.

This editorial process does not replace a planned usability evaluation. Establish applicable evidence requirements separately and route editing findings to the design and risk management owners. Missing product evidence cannot justify a conclusion that testing is exempt.

6. Release the complete information set together

Create one final list of Korean model and consumable combinations, labels, quick-start information, full instructions, screens and app versions. Record approvals and revisions. When an overseas manufacturer notifies a change, trace the affected translations and interfaces. These records also link complaints and user questions to the version supplied.

Send the manufacturer instructions and Korean sales configuration to request a home-use documentation review. Clare Partners can distinguish translation checks from further safe-use evidence questions.

Official references: MFDS consumer safe-use guidance · Korean Regulation on Medical Device Approval, Notification and Review. Checked 2026-09-28. Tables and editorial steps are practical recommendations, not substitutes for product-specific rules or usability evidence requirements.